A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism
- PMID: 8840307
- DOI: 10.1093/ndt/11.supp3.22
A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism
Abstract
Secondary hyperparathyroidism (HPT) develops early in chronic renal failure (CRF) at a time when plasma calcitriol levels are normal. At this time, PTH are higher than normal controls and serum phosphorous levels are lower. A decrement in total serum Ca is noted, after an oral phosphate load, only in patients with ERF. These data suggest that factors, other than a decrease in calcitriol synthesis, may be involved in the pathogenesis of HPT. A hypothesis is forwarded suggesting that an alteration in the newly cloned calcium sensor receptor may be the earliest abnormality in the HPT, preceding a decrease in plasma calcitriol levels.
Similar articles
-
The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure.Am J Kidney Dis. 1997 Apr;29(4):496-502. doi: 10.1016/s0272-6386(97)90330-9. Am J Kidney Dis. 1997. PMID: 9100037 Clinical Trial.
-
Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol).Nephron. 1995;70(3):287-95. doi: 10.1159/000188606. Nephron. 1995. PMID: 7477615
-
Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited.Am J Kidney Dis. 1995 May;25(5):663-79. doi: 10.1016/0272-6386(95)90541-3. Am J Kidney Dis. 1995. PMID: 7747720 Review.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure.Kidney Int. 2000 Sep;58(3):981-8. doi: 10.1046/j.1523-1755.2000.00255.x. Kidney Int. 2000. PMID: 10972662 Clinical Trial.
Cited by
-
Vitamin D and the Immune System from the Nephrologist's Viewpoint.ISRN Endocrinol. 2014 Jan 22;2014:105456. doi: 10.1155/2014/105456. eCollection 2014. ISRN Endocrinol. 2014. PMID: 24587915 Free PMC article. Review.
-
Role of vitamin D in the pathogenesis of atheromatosis.Nutr Metab Cardiovasc Dis. 2021 Jan 4;31(1):344-353. doi: 10.1016/j.numecd.2020.08.031. Epub 2020 Sep 12. Nutr Metab Cardiovasc Dis. 2021. PMID: 33500110 Free PMC article.
-
Cytochrome P450-mediated metabolism of vitamin D.J Lipid Res. 2014 Jan;55(1):13-31. doi: 10.1194/jlr.R031534. Epub 2013 Apr 6. J Lipid Res. 2014. PMID: 23564710 Free PMC article. Review.
-
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.Kidney Int. 2011 Jun;79(12):1370-8. doi: 10.1038/ki.2011.47. Epub 2011 Mar 9. Kidney Int. 2011. PMID: 21389978 Free PMC article.
-
Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease.Drugs. 2007;67(14):1999-2012. doi: 10.2165/00003495-200767140-00003. Drugs. 2007. PMID: 17883284 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources